Pfizer taps Citi’s Baum for C-level pipeline management and strategy role

Pfizer Inc. (NYSE:PFE) hired Andrew Baum for a C-level role in which the former equity research analyst will have responsibility for setting pipeline priorities as the pharma executes on a strategic plan unveiled in January.

Baum will join Pfizer after 13 years at Citi, where he was head of global healthcare and managing director for equity research. Once a practicing physician, Baum also spent 14 years at Morgan Stanley before joining Citi...